drugset / Trial / NCT01617460

A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder

NCT01617460

Phase 3 Completed 86 enrolled Otsuka Pharmaceutical Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to investigate the safety and efficacy of aripiprazole orally administered over long term in subjects who complete a short-term treatment study of pediatric Autistic Disorder (031-11-002 study).

Timeline

Start
2012-09
Primary completion
2016-10
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified Oral

Indications